Bio preparedness: Responding to Future Biological Threats

The COVID pandemic caught the U.S. and the world off guard in 2020. Nearly three years later are we prepared for the next biological threat? Do we have strategies for developing treatments and vaccines and the supply chains to deploy them? Hear from Dr. Julie Gerberding of the Foundation for the National Institutes of Health; Dr. Matthew Hepburn, who leads pandemic preparedness for the White House Office of Science and Technology Policy; and Dr. Monique K. Mansoura of MITRE.

Mansoura co-led a team that developed MITRE’s 10-point action plan on sustaining a biopharma industrial base to enhance our health, economic and national security. Hepburn leads a White House team that recently published a progress report on the nation’s pandemic preparedness.